BioVie, Inc. (BIVI) financial statements (2021 and earlier)

Company profile

Business Address 2120 COLORADO AVE.
LOS ANGELES, CA 90404
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1200000
Cash and cash equivalents1200000
Prepaid expense     0
Other current assets000   
Other undisclosed current assets    (0) 
Total current assets:1201000
Noncurrent Assets
Property, plant and equipment    (0) 
Intangible assets, net (including goodwill)222223
Goodwill000000
Intangible assets, net (excluding goodwill)112222
Other undisclosed noncurrent assets    0 
Total noncurrent assets:222223
Other undisclosed assets    0 
TOTAL ASSETS:1323223
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities010111
Accounts payable010100
Employee-related liabilities   000
Due to related parties    00
Other undisclosed current liabilities 22    
Total current liabilities:0240111
Noncurrent Liabilities
Long-term debt and lease obligation00    
Long-term debt, excluding current maturities00    
Liabilities, other than long-term debt   10 
Accounts payable and accrued liabilities    0 
Due to related parties   1  
Other undisclosed noncurrent liabilities   00 
Total noncurrent liabilities:00 11 
Total liabilities:0240211
Stockholders' equity
Stockholders' equity attributable to parent, including:13(21)2012
Common stock000000
Additional paid in capital103209533
Accumulated deficit(90)(41)(7)(5)(2)(1)
Other undisclosed stockholders' equity attributable to parent    0 
Other undisclosed stockholders' equity   (0)  
Total stockholders' equity:13(21)2012
Other undisclosed liabilities and equity   0  
TOTAL LIABILITIES AND EQUITY:1323223

Income statement (P&L) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Gain (loss) on disposition of assets for financial service operations8(9) 
Net investment income  0 0 
Gross profit:(8) 0 0 
Operating expenses(5)(3)(2)(2)(2)(0)
Other undisclosed operating income (loss)89(0) (0) 
Operating loss:(5)(3)(2)(2)(2)(0)
Interest and debt expense(3)(5)(0)(0)0(0)
Loss before gain (loss) on sale of properties:(8)(7)(2)(2)(1)(0)
Other undisclosed net income (loss)(26)(9)00  
Net loss:(34)(17)(2)(2)(1)(0)
Other undisclosed net income (loss) attributable to parent0  (0)00
Net loss available to common stockholders, diluted:(34)(17)(2)(2)(1)(0)

Comprehensive Income ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss:(34)(17)(2)(2)(1)(0)
Comprehensive loss, net of tax, attributable to parent:(34)(17)(2)(2)(1)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: